Tumor necrosis factor-α converting enzyme inactivation ameliorates high-fat diet-induced insulin resistance and altered energy homeostasis

Circulation Journal

Volumn 75, Issue 10, 2011, Pages 2482-2490

  Kaneko, Hidehiro ^b   Anzai, Toshihisa ^a,b   Horiuchi, Keisuke ^a   Morimoto, Kokichi ^b   Anzai, Atsushi ^a   Nagai, Toshiyuki ^a   Sugano, Yasuo ^b   Maekawa, Yuichiro ^a   Itoh, Hiroshi ^b   Yoshikawa, Tsutomu ^a   Okada, Yasunori ^b   Ogawa, Satoshi ^a,b   Fukuda, Keiichi ^a  

^a International University of Health and Welfare Mita Hospital   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine; Inflammation; Insulin resistance; Metabolism; Obesity

Indexed keywords

ADIPONECTIN; GLUCOSE; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIMETRY; CARBOHYDRATE METABOLISM; CELL INFILTRATION; CELL SIZE; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; ENZYME ACTIVITY; ENZYME INACTIVATION; EPIDIDYMIS FAT; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEMODYNAMICS; HOMEOSTASIS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; MACROPHAGE; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYSTOLIC BLOOD PRESSURE;

ADAM PROTEINS; ADIPOSE TISSUE; ANIMALS; DIETARY FATS; ENERGY METABOLISM; FATTY LIVER; GENE DELETION; HOMEOSTASIS; INSULIN RESISTANCE; MICE; MICE, TRANSGENIC; OBESITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053085356     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0182     Document Type: Article

References (33)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
2. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: Transition from theory to practice. Circ J 2010; 74: 213-220.
3. Walsh K. Adipokines, myokines and cardiovascular disease. Circ J 2009; 73: 13-18.
4. Oda E. Obesity-related risk factors of cardiovascular disease. Circ J 2009; 73: 2204-2205.
5. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
6. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-614.
7. Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, Pasparakis M, et al. Targeted disruption of the tumor necrosis factor-alpha gene: Metabolic consequences in obese and nonobese mice. Diabetes 1997; 46: 1526-1531.
8. Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: Multidomain proteins with multiple functions. Genes Dev 2003; 17: 7-30.
9. Menghini R, Menini S, Amoruso R, Fiorentino L, Casagrande V, Marzano V, et al. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology 2009; 136: 663-672; e664.
10. Fiorentino L, Vivanti A, Cavalera M, Marzano V, Ronci M, Fabrizi M, et al. Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology 2010; 51: 103-110.
11. Gelling RW, Yan W, Al-Noori S, Pardini A, Morton GJ, Ogimoto K, et al. Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice. Endocrinology 2008; 149: 6053-6064.
12. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science 1995; 269: 1427-1429.
13. Jackson LF, Qiu TH, Sunnarborg SW, Chang A, Zhang C, Patterson C, et al. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 2003; 22: 2704-2716.
14. Horiuchi K, Kimura T, Miyamoto T, Takaishi H, Okada Y, Toyama Y, et al. Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J Immunol 2007; 179: 2686-2689.
15. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S, et al. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 1993; 268: 11617-11621.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
17. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
18. Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, Kohno T, et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1510-1520.
19. Konner AC, Bruning JC. Toll-like receptors: Linking inflammation to metabolism. Trends Endocrinol Metab 2011; 22: 16-23.
20. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
21. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8: 731-737.
22. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995; 83: 793-802.
23. Xu H, Sethi JK, Hotamisligil GS. Transmembrane tumor necrosis factor (TNF)-alpha inhibits adipocyte differentiation by selectively activating TNF receptor 1. J Biol Chem 1999; 274: 26287-26295.
24. Xu H, Hirosumi J, Uysal KT, Guler AD, Hotamisligil GS. Exclusive action of transmembrane TNF alpha in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology 2002; 143: 1502-1511.
25. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006; 116: 115-124.
26. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
27. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 2005; 25: 2062-2068.
28. Schreyer SA, Chua SC Jr, LeBoeuf RC. Obesity and diabetes in TNF- alpha receptordeficient mice. J Clin Invest 1998; 102: 402-411.
29. Arribas J, Esselens C. ADAM17 as a therapeutic target in multiple diseases. Curr Pharm Des 2009; 15: 2319-2335.
30. Sibilia M, Wagner B, Hoebertz A, Elliott C, Marino S, Jochum W, et al. Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart. Development 2003; 130: 4515-4525.
31. Karkkainen I, Rybnikova E, Pelto-Huikko M, Huovila AP. Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol Cell Neurosci 2000; 15: 547-560.
32. Sibilia M, Steinbach JP, Stingl L, Aguzzi A, Wagner EF. A strainindependent postnatal neurodegeneration in mice lacking the EGF receptor. EMBO J 1998; 17: 719-731.
33. Wang X, Oka T, Chow FL, Cooper SB, Odenbach J, Lopaschuk GD, et al. Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis. Hypertension 2009; 54: 575-582.